Kingston FURY DDR4 UDIMMs Get a New Look
Kingston FURY Renegade DDR4 RGB & Non-RGB Kingston FURY Beast DDR4 RGB Optimized for Intel®…
Month: October 2023
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
ROCKVILLE, Md., Oct. 09, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
ROCKVILLE, Md., Oct. 09, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
Harpoon Therapeutics to Present Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a…
Harpoon Therapeutics to Present Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a…
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
PHAXIAM Therapeutics announces high coverage performanceof its two anti-Staphylococcus aureus phages over clinical strains Data…
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
PHAXIAM Therapeutics announces high coverage performanceof its two anti-Staphylococcus aureus phages over clinical strains Data…
Akero Therapeutics to Present Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis Due to NASH
Investor webcast on Tuesday, October 10 at 8:00 a.m. ET to present clinical data SOUTH…
Akero Therapeutics to Present Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis Due to NASH
Investor webcast on Tuesday, October 10 at 8:00 a.m. ET to present clinical data SOUTH…
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients
INPEFA recently approved by FDA for treatment of heart failure Express Scripts has determined that…
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients
INPEFA recently approved by FDA for treatment of heart failure Express Scripts has determined that…
Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis
VTX002 60 mg achieved the primary endpoint of clinical remission with a high rate of…
Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis
VTX002 60 mg achieved the primary endpoint of clinical remission with a high rate of…
MDxHealth Reports Preliminary Q3-2023 Revenues
NEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET …
MDxHealth Reports Preliminary Q3-2023 Revenues
NEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET …
Silicon Ranch and SSVEC Celebrate the Completion of McNeal Solar and Battery Storage Project in Southeastern Arizona
State-of-the-art facility includes 20 MW of solar energy plus 80 MWh battery energy storage system…
AIS (Archipelagic & Island States) Forum 2023 highlights Blue Economy to mitigate climate change
BALI, Oct 9, 2023 – (ACN Newswire) – The Archipelagic & Island States (AIS) Forum,…
Colbeck Capital to Support Pink Aid’s 13th Annual Luncheon & Fashion Show
NEW YORK–(BUSINESS WIRE)–Colbeck Capital Management (“Colbeck”) today announced its continued support of Pink Aid (the…
Qualus Acquires GridBright, A Leading Power Industry Technology Solutions Firm, Expanding Its Services and Differentiated Market Position
ORLANDO, Fla.–(BUSINESS WIRE)–Qualus Corporation, a leading power consulting, engineering, and technical services firm announced today…
Capstone Green Energy Transitions to OTC Expert Market Following Nasdaq Delisting
LOS ANGELES–(BUSINESS WIRE)–$CGRNQ #CleanPower—Capstone Green Energy Corporation (OTC: CGRNQ) (the Company or Capstone) received FINRA’s…